301
Participants
Start Date
June 30, 2008
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
Cognis 100-D, Teligen DR and VR 100 HE
Teligen is an implantable defibrillator for detection and termination of life threatening arrhythmias. Cognis includes in addition to these capabilities cardiac resynchronization therapy for patients having heart failure.
Paul Stradina Clinical University Hospital, Riga
University Hospital of Geneva, Geneva
Hartcentrum Hasselt - Dienst Cardiologie, Hasselt
KH der Elisabethinen Linz, Linz
Amphia Ziekenhius Breda, Breda
KH der Barmherzigen Schwestern Ried/Innkreis, Ried
Ziekenhius Rijnstate Arnhem, Arnhem
CHU Dijon - Hospital du Bocage, Dijon
EHRU de Brest - Hospital de la Cavale Blanche, Brest
Hospital Universitario Central de Asturias, Oviedo
Klinikum Kassel, Kassel
Klinikum Fulda, Fulda
CHU de Tours, Tours
CHU de St. Etienne-Hospital Nord, Saint-Priest-en-Jarez
Marienhospital Herne, Herne
CHR Orléans - Hospital la Source, Orléans
Clinico Universitario de Valladolid, Valladolid
Centro Miguel Servet, Zaragoza
Kerckhoff-Klinik GmbH, Bad Nauheim
University Hospital of Heraklion, Heraklion
CMC Parly II, Parly
Narodny ustav srdcvych a cievnych chorob, Bratislava
Klinikum Nuernberg, Nuremberg
Praxis Dres. Bischoff/Lang, Erfurt
Prince of Wales Hospital, Hong Kong
Praxis Schnabel der Praxisgemeinschaft Kardiologie Meissen, Meissen
Klinikum Dorothea Christiane Erxleben Quedlinburg GmbH, Quedlinburg
Hospital Son Llatzer, Palma de Mallorca
Lead Sponsor
Collaborators (1)
Guidant Corporation
INDUSTRY
Boston Scientific Corporation
INDUSTRY